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Infection by Borna disease virus (BDV) enables the study of the molecular mechanisms whereby a virus can persist in
the central nervous system and lead to altered brain function in the absence of overt cytolysis and inflammation. This
neurotropic virus infects a wide variety of vertebrates and causes behavioral diseases. The basis of BDV-induced
behavioral impairment remains largely unknown. Here, we investigated whether BDV infection of neurons affected
synaptic activity, by studying the rate of synaptic vesicle (SV) recycling, a good indicator of synaptic activity. Vesicular
cycling was visualized in cultured hippocampal neurons synapses, using an assay based on the uptake of an antibody
directed against the luminal domain of synaptotagmin I. BDV infection did not affect elementary presynaptic
functioning, such as spontaneous or depolarization-induced vesicular cycling. In contrast, infection of neurons with
BDV specifically blocked the enhancement of SV recycling that is observed in response to stimuli-induced synaptic
potentiation, suggesting defects in long-term potentiation. Studies of signaling pathways involved in synaptic
potentiation revealed that this blockade was due to a reduction of the phosphorylation by protein kinase C (PKC) of
proteins that regulate SV recycling, such as myristoylated alanine-rich C kinase substrate (MARCKS) and Munc18–1/
nSec1. Moreover, BDV interference with PKC-dependent phosphorylation was identified downstream of PKC
activation. We also provide evidence suggesting that the BDV phosphoprotein interferes with PKC-dependent
phosphorylation. Altogether, our results reveal a new mechanism by which a virus can cause synaptic dysfunction and
contribute to neurobehavioral disorders.
Citation: Volmer R, Monnet C, Gonzalez-Dunia D (2006) Borna disease virus blocks potentiation of presynaptic activity through inhibition of protein kinase C signaling. PLoS
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Introduction
Viruses can affect brain functioning in several ways. In
some cases, viral replication causes neuronal death directly,
as in the manner of rabies virus or alphaviruses, which induce
neuronal apoptosis [1,2]. Alternatively, neurons can be
damaged by immune cytotoxicity or by neurotoxic factors
produced by inﬁltrating mononuclear cells or infected glial
cells [3]. Viruses can also persist in neurons and cause
neurological diseases without overt cytopathic effect or
inﬂammation [4]. This has led to the hypothesis that
persistent viruses could play a role in human mental
disorders of unclear etiology [5,6]. It also has provided
further impetus to understand the molecular mechanisms
underlying virus-induced neuronal dysfunction.
Borna disease virus (BDV) is an attractive paradigm for
investigating the mechanisms of neurobehavioral disorders
due to the persistence of a non-cytolytic virus. BDV is an
enveloped virus with a non-segmented, negative strand RNA
genome [7,8]. BDV infects a wide variety of mammals [9], and
serological evidence suggests that BDV, or a BDV-like virus,
also infects humans [10,11]. Infected hosts develop a large
spectrum of neurological disorders, ranging from immune-
mediated diseases to behavioral alterations without inﬂam-
mation [9,12], reminiscent of symptoms observed in human
psychiatric diseases such as schizophrenia, mood disorders,
and autism [13]. These neurobehavioral manifestations reﬂect
the remarkable localization of BDV in the central nervous
system (CNS). The virus targets mainly neurons of the limbic
system and persists primarily in the hippocampus [14].
The molecular bases for the cognitive impairment of BDV-
infected animals remain to be determined. Since BDV is non-
cytolytic, it was suggested that BDV interferes with signaling
pathways that are important for proper neuronal functioning
[5,15]. This hypothesis was corroborated by the observation
that BDV reduces the expression of proteins involved in
synaptic remodeling [16] and blocks the response of neurons
to neurotrophins [17]. However, no study has tested directly
the impact of BDV infection on synaptic transmission and on
activity-dependent plasticity.
Synaptic transmission is initiated by the release of neuro-
transmitters through exocytosis of synaptic vesicles (SV).
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endocytosed and reﬁlled with neurotransmitters. This cycle
of exo-endocytosis, termed SV recycling, allows SV to be
reused for subsequent neurotransmitter release. SV recycling
is essential to maintain efﬁcient synaptic transmission and is
tightly regulated [18]. In recent years, evidence has accumu-
lated showing that changes in the rate of SV recycling
modulate synaptic activity and contribute to synaptic
plasticity. For example, it has been shown that vesicular
cycling increases markedly during long-term potentiation
(LTP), a form of synaptic plasticity that is thought to underlie
forms of learning and memory at the cellular level [19,20]. It
is also conceivable that a loss of proper regulation of SV exo-
endocytosis could contribute to cognitive and behavioral
impairment associated with BDV infection.
The goal of the present work was to examine the impact of
BDV infection on synaptic activity, by analyzing SV recycling.
We used infected primary cultures of hippocampal neurons
and measured the rate of vesicular cycling under spontaneous
conditions or after different stimulation procedures. Here, we
report that BDV selectively blocks activity-dependent en-
hancement of SV recycling, whereas it does not affect
spontaneous or depolarization-induced vesicular cycling. We
also analyzed signaling pathways that play important roles for
presynapticpotentiationandfoundthatthisblockadeislinked
to an interference with protein kinase C (PKC) signaling.
Finally, we show that transfection of BDV phosphoprotein (P)
in neurons leads to impaired PKC-dependent phosphoryla-
tion. Thus, we provide a cellular and molecular basis for the
learning disabilities associated with BDV infection.
Results
Synapse Integrity and Basal and Evoked Presynaptic
Activities Are Unaffected by BDV
We used hippocampal neurons which had been cultured
and infected for 14 d. At that time point, the neurons have
established mature synapses and the virus has spread to all of
them [21,22]. No differences were found in the expression of
proteins involved in synaptic transmission (Figure 1A),
conﬁrming that BDV infection does not impair synaptic
protein expression [17]. To study whether BDV replication
affected synaptic activity, we analyzed SV recycling with an
assay based on the uptake of a monoclonal antibody targeted
against the luminal domain of the vesicular protein synapto-
tagmin I (Syt-ecto; Figure 1B and 1C). Living neurons were
ﬁrst incubated with Syt-ecto in order to speciﬁcally label
vesicles that have fused at the plasma membrane. Thereafter,
the cultures were ﬁxed and stained with a polyclonal antibody
recognizing the cytoplasmic domain of synaptotagmin I
(total-Syt). After image acquisition, the regions of interest
corresponding to synapses were identiﬁed in the total-Syt
channel (detected by an anti-rabbit FITC, ﬂuorescence F2).
Fluorescence intensity in the Syt-ecto channel (using an anti-
mouse-Cy3, ﬂuorescence F1) was quantiﬁed within the same
region. We then calculated the ratio of ﬂuorescence
intensities F1/F2 to obtain a normalized measurement of SV
recycling. The speciﬁcity of Syt-ecto (F1) staining was
demonstrated by loss of labeling after overnight treatment
with botulinum B toxin, which cleaves VAMP-2 protein and
abrogates SV recycling [23] (Figure 1C, bottom panels). To
avoid any bias in the measurements of ﬂuorescence ratios, we
also veriﬁed that total-Syt ﬂuorescence (F2) did not differ
between control and BDV-infected neurons (Figure 1D),
consistent with Western blot results for synaptotagmin I
shown on Figure 1A.
In a ﬁrst set of experiments, we measured basal presynaptic
activity in the presence of blockers of endogenous neuronal
activity, i.e., TTX, APV, and CNQX, so that SV recycling is
due to spontaneous fusion and recovery of vesicles, without
ﬁring of action potentials or activity due to endogenous
glutamate release (Figure 2) [20]. Under these conditions, the
level of SV recycling was low and did not differ between
control and BDV-infected neurons (Figure 2A and 2C).
Likewise, when neurons were subjected to an extended
depolarization, we observed the same enhancement of SV
recycling for control and BDV-infected neurons, likely due to
the mobilization of the entire pool of recycling SV (Figure 2B
and 2C) [24]. Together, these data indicate that infection with
BDV has no impact on basal presynaptic activity or on the
ability to respond to a prolonged depolarization.
BDV Impairs Activity-Dependent Potentiation of Vesicular
Recycling
Previous studies have demonstrated that an increase of SV
recycling is important for certain forms of synaptic plasticity,
and in particular for the expression of LTP [19,20]. These
ﬁndings prompted us to ask whether BDV replication
impacted the enhancement of SV recycling observed in
response to stimuli-induced synaptic potentiation. Indeed,
after repetitive depolarization using high K
þ pulses [25], we
observed that SV recycling was strongly enhanced in control
neurons, but only modestly in BDV-infected neurons (Figure
3A). No enhancement of SV recycling was observed when
neurons were stimulated in the absence of calcium, conﬁrm-
ing that calcium inﬂux is necessary to trigger potassium-
induced potentiation. Similar results were found when
neurons were stimulated with glycine, which has been shown
to induce LTP in hippocampal neurons in culture [26,27]. An
increase in SV recycling was detected after washout of glycine
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Synopsis
The central nervous system is the target of many persistent viral
infections that can induce diverse pathological manifestations.
Besides causing meningitis or encephalitis, viruses can infect
neurons without overt structural damage, but nevertheless alter
cellular functioning by yet-undefined molecular mechanisms, there-
by disturbing homeostasis and causing disease. Here, the authors
have studied the infection by Borna disease virus, an RNA virus that
persists in the brain of a wide variety of animals and causes
behavioral disturbances. Using primary cultures of neurons, they
show that Borna disease virus interferes specifically with the activity-
dependent enhancement of synaptic activity, one form of synaptic
plasticity that is believed to be essential for memory formation. This
interference was correlated to a reduced phosphorylation of
neuronal targets by protein kinase C (PKC), a kinase that plays
important roles in the regulation of neuronal activity. The authors
also provide evidence that the viral phosphoprotein may be
responsible for this interference, possibly by competing with the
phosphorylation of endogenous cellular PKC substrates. These
results illustrate an intriguing aspect of viral interference with
neuronal function and reveal a new mechanism whereby a virus can
cause synaptic dysfunction and contribute to neurobehavioral
disorders.in control neurons, whereas no enhancement (and even a
statistically signiﬁcant reduction) was observed in BDV-
infected neurons (Figure 3B). The increase in SV recycling
in control neurons was prevented when the N-methyl-D-
aspartate (NMDA) receptor blocker APV was added, consis-
tent with the requirement of NMDA receptor activation for
glycine-induced LTP [26]. Note that glycine, a milder stimulus
than high K
þ pulses, led to less pronounced enhancement of
SV recycling in control neurons. Thus, BDV infection
interferes with activity-dependent changes in presynaptic
activity induced by two different stimulation procedures.
BDV Interferes with PKC-Dependent Synaptic Potentiation
Signaling by several protein kinases plays important roles
during the early phase of synaptic potentiation. In particular,
extracellular-regulated kinase (ERK) 1/2, protein kinase A
(PKA), Ca
2þ/calmodulin-dependent kinase (CaMK) II, and
PKC phosphorylate presynaptic proteins that modulate SV
recycling [28,29]. Thus, we tested the hypothesis that BDV-
mediated block in the enhancement of SV recycling could be
due to an interference with protein kinase signaling, by using
Western blot analyses with phospho-speciﬁc antibodies.
Following stimulation of neurons with glycine, we observed
that ERK 1/2 phosphorylation was not affected by BDV
infection (Figure 4A). In addition, staining for synapsin I
phosphorylated at either site 3 or site 1, two sites speciﬁc for
CaMK II and PKA/CaMK I, respectively [30], showed that BDV
did not interfere with signaling by these kinases (Figure 4B
and 4C). In contrast, the phosphorylation of myristoylated
alanine-rich C kinase substrate (MARCKS), a major PKC
substrate in neurons [31], was severely impaired in BDV-
infected neurons following treatment with glycine (Figure
4D). The phosphorylation of MARCKS was also impaired in
BDV-infected neurons following exposure to high K
þ pulses,
although we observed a higher variability between experi-
ments, likely due to the stronger effects of this stimulation
procedure compared to glycine (unpublished data).
To further determine the level of BDV interference with
PKC signaling, we investigated whether BDV interference
with synaptic potentiation was still observed after direct
activation of PKC by phorbol 12-myristate 13-acetate (PMA).
Phorbol esters, such as PMA, have been shown to enhance
vesicular cycling through the presynaptic PKC/munc-13
signaling cascades [32,33]. Although treatment with PMA led
to an increase in SV recycling in both control and BDV-
infected neurons, the level of potentiation was much lower in
BDV-infected neurons (Figure 5A). In neurons treated with
the PKC inhibitor Bis, potentiation of presynaptic activity
was almost completely abolished, indicating that the majority
of the PMA-induced enhancement of vesicular cycling could
indeed be attributed to PKC signaling. We also analyzed PKA-
dependent enhancement of SV recycling by stimulating PKA
directly with forskolin [34]. Consistent with the analysis of
synapsin I phosphorylation at site 1 (Figure 4C), we observed
that forskolin enhanced SV recycling to the same extent in
control and BDV-infected neurons (Figure 5B).
We then analyzed the phosphorylation of PKC substrates
following direct stimulation of PKC by PMA. We showed by
Western blot analysis that the phosphorylation of MARCKS
and Munc18–1/nSec1 (Munc18), two PKC substrates that have
been implicated in the regulation of vesicular recycling
Figure 1. Synapse Integrity Is Preserved in Neurons Persistently Infected with BDV
(A) Western blots of neuronal extracts. Comparative analysis of the expression levels of a panel of neuronal proteins from non-infected (NI) and BDV-
infected cultures. Results are representative of three independent experiments.
(B) Outline of the experimental protocol to measure vesicular cycling at synapses. In a first step, recycling vesicles are labeled with a mouse monoclonal
antibody directed against the luminal domain of synaptotagmin 1 (Syt-ecto). After washes, neurons are fixed and permeabilized and incubated with a
rabbit antibody directed against the cytoplasmic domain of synaptotagmin 1 (Total-Syt).
(C) Examples of Syt-ecto and total-Syt labeling. Bottom panels show neurons treated with botulinum B toxin (Bot B). Bar: 20 lm.
(D) Quantification of total-Syt fluorescence staining (n ¼ 381 and 386 synapses for BDV-infected and NI neurons, respectively).
DOI: 10.1371/journal.ppat.0020019.g001
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BDV Inhibition of Synaptic Potentiation[31,35], was impaired in BDV-infected neurons following
direct stimulation of PKC by PMA (Figure 6A and 6B).
BDV Interferes with PKC Signaling Downstream of PKC
Activation
BDV could interfere with PKC signaling by inhibiting PKC
recruitment to membranes, an essential step in PKC
activation [36]. We therefore examined the cytosol-to-
membrane translocation of PKC isoforms a, c, e, and d [37]
and showed that BDV infection did not interfere with
membrane translocation of these PKC isoforms following
PMA treatment (Figure 7A). In addition, both basal and
cofactor-stimulated PKC activities, measured using an in
vitro kinase assay, did not differ between control and BDV-
infected neurons (Figure 7B). Thus, BDV infection does not
alter the ability of PKC to be activated. Altogether, these data
indicate that BDV interferes with PKC signaling downstream
of PKC activation.
Previously, it has been shown that the BDV P is
phosphorylated by PKC in vivo and in vitro [38]. In addition,
P is strongly expressed in infected neurons. Thus, we
hypothesized that P could compete with the phosphorylation
of endogenous PKC substrates. In order to test this
hypothesis, we transfected primary neurons with vectors
expressing P, but also BDV nucleoprotein (N), the other
strongly expressed viral protein, as well as green ﬂuorescent
protein (GFP) as a control. Expression of P was sufﬁcient to
decrease signiﬁcantly the phosphorylation of MARCKS after
stimulation with PMA, whereas N or GFP had no effect
(Figure 8A). Transfection experiments using increasing
quantities of P plasmid showed that this inhibitory effect on
the phosphorylation of MARCKS was dose dependent (Figure
8B and 8C). Interestingly, the subcellular localization of BDV
P varied depending on the amount of P plasmid used.
Starting at 0.3 lg BDV P plasmid, we observed that P was
detected not only in the nucleus, but also in neuronal
processes (Figure 8B). We also showed that P was phosphory-
Figure 3. BDV Blocks Activity-Dependent Potentiation of Vesicular
Recycling
Cumulative probability distributions of fluorescence ratios (F1/F2) for
individual synapses for the analysis of SV recycling in spontaneous
conditionsandafter:(A)repetitivedepolarizationwithhigh-K
þpulsesor(B)
glycine treatment. The overview of the experimental stimulation protocol
isdepictedaboveeachgraph.ThelevelofSVrecyclingissignificantlylower
in BDV-infected neurons compared to NI neurons following stimulation
with high-K
þ pulses or glycine treatment (p , 0.001 using KS test). Note
that SV recycling is even reduced after glycine treatment in BDV-infected
neurons. Pairwise comparisons of mean presynaptic activities in inde-
pendent experiments involved at least 300 synapses (small symbols).
Biggersquarescorrespondtomeanvaluesofallindependentexperiments.
Similar results were found in three to seven independent experiments.
Hash mark (#) indicates p , 0.05 by paired t test.
DOI: 10.1371/journal.ppat.0020019.g003
Figure 2. Spontaneous and Evoked SV Recycling Are Not Affected by
BDV Infection
(A) Cumulative probability distributions of fluorescence ratios (F1/F2) for
individualsynapsesforspontaneousSVrecycling.Nodifferenceisobserved
between control (NI) and BDV-infected neurons (p¼0.112, KS test).
(B) Cumulative probability distributions of fluorescence ratios (F1/F2) for
individual synapses for 70 mM K
þ evoked and spontaneous SV recycling.
In both NI and BDV-infected neurons, the level of SV recycling is
significantly increased in neurons stimulated with 70 mM K
þ (p , 0.001,
KS test). The overview of the experimental stimulation protocol is
depicted above each graph.
(C) Pairwise comparisons of mean presynaptic activities in independent
experiments involving at least 300 synapses (small symbols). Bigger
squares correspond to mean values of all independent experiments. n.s.,
not significant using paired t test.
DOI: 10.1371/journal.ppat.0020019.g002
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BDV Inhibition of Synaptic Potentiationlated at serine residues following treatment with PMA (Figure
8D), in agreement with the previous demonstration that P is
phosphorylated by PKC.
Discussion
Here, we show that hippocampal neurons infected with
BDV become unresponsive to synaptic potentiation. We
further demonstrate that this phenotype is linked to an
impairment of PKC signaling, and we provide evidence that
BDV P interferes with the phosphorylation of endogenous
PKC substrates in neurons. To our knowledge, this is the ﬁrst
demonstration of the direct effect of a viral infection on
activity-dependent synaptic plasticity, representing an intri-
guing aspect of viral interference with neuronal functioning.
Remarkably, basal and evoked presynaptic activities were
not affected in BDV-infected neurons. This correlates well
with the total lack of cytopathic effect of BDV, which can
infect primary neurons with high efﬁcacy without impairing
neuronal growth or expression of neuron-speciﬁc markers
[17]. It also suggests that the active replication of BDV in
neurons and the accumulation of viral proteins at synapses
[22] does not lead to a generalized defect in presynaptic
function.
The BDV-induced blockade in PKC signaling was also
observed after direct activation of PKC by the agonist PMA.
On the contrary, the PKA agonist forskolin induced similar
enhancement of vesicular cycling in control and BDV-
infected neurons, demonstrating that the cAMP/PKA signal-
ing cascade is not targeted by infection. These ﬁndings
underline the speciﬁcity of BDV interference with PKC-
Figure 4. PKC Signaling Is Impaired in BDV-Infected Neurons
Western blots of neuronal extracts from NI and BDV-infected cultures
stimulated with glycine using antibodies specific for: (A) Diphosphory-
lated ERK 1/2 (pERK) and total ERK 1/2; (B) phospho-synapsin I
(pSynapsin I; Site 3, a site specific for CaMK II), and total synapsin I; (C)
phospho-synapsin I (Site 1, a site specific for PKA and CamK I) and total
synapsin I; (D) phospho-MARCKS (pMARCKS; PKC site at Ser152/156) and
b-tubulin III. Results are representative of four independent experiments.
Single asterisk (*) indicates p , 0.05; double asterisks (**) indicate p ,
0.01 by unpaired t test.
DOI: 10.1371/journal.ppat.0020019.g004
Figure 5. PMA, but Not Forskolin-Induced Potentiation of Vesicular
Recycling Is Impaired in BDV-Infected Neurons
Cumulative probability distributions of fluorescence ratios (F1/F2) for
individual synapses for the analysis of SV recycling in spontaneous
conditions and after (A) PMA treatment or (B) forskolin treatment. The
overview of the experimental stimulation protocol is depicted above
each graph. The level of SV recycling is significantly lower in BDV-
infected neurons compared to NI neurons after stimulation with PMA (p
, 0.001 using KS test). Pairwise comparisons of mean presynaptic
activities in independent experiments involved at least 180 synapses
(small symbols). Bigger squares correspond to mean values of all
independent experiments. Similar results were found in four independ-
ent experiments. Also shown are results for NI neurons treated with the
PKC inhibitor Bis or the PKA inhibitor H89. Hash mark (#) indicates p ,
0.05. n.s., not significant, by paired t test.
DOI: 10.1371/journal.ppat.0020019.g005
Figure 6. Analysis of PKC Signaling in NI and BDV-Infected Neurons
Western blot analyses of (A) MARCKS and (B) Munc18 phosphorylation
by PKC. b-Tubulin III and total Munc18 were used to normalize
expression. Results are representative of three to five independent
experiments. Double asterisks (**) indicate p , 0.01. n.s., not significant,
using unpaired t test.
DOI: 10.1371/journal.ppat.0020019.g006
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are still capable of presynaptic potentiation, as long as PKC
signaling is not required.
Viral interference with PKC signaling has often been
correlated with the inhibition of the cytosol-to-membrane
translocation of a speciﬁc PKC isozyme, due to the
interaction of a viral protein with the anchoring protein
RACK1 (receptor for activated PKC). Some examples of such
an inhibition include the Nef protein from human immuno-
deﬁciency virus or the Zebra protein from Epstein-Barr virus
[39,40]. In contrast, we showed here that the activation and
membrane translocation of PKC isoforms were not affected
by BDV infection. Rather, BDV blocked the phosphorylation
of PKC neuronal substrates, such as MARCKS and Munc18,
which play essential roles in vesicular cycling. The phosphor-
Figure 7. Analysis of PKC Activation
(A) Cytosol-to-membrane recruitment of PKC. Subcellular distribution of
PKC isoforms in NI and BDV-infected neurons after treatment with PMA.
The detergent-soluble and particulate fractions, corresponding to
cytosolic and membrane fractions, were subjected to Western blots for
the detection of PKCa, PKCc, PKCe, and PKCd. Note the shift in the
subcellular distribution of PKC isoforms after treatment with PMA.
Results are representative of three independent experiments.
(B) In vitro measurements of basal and cofactor-stimulated PKC activities.
The cofactor-stimulated specific activity represents kinase activity in the
presence of Ca
2þ and lipid activators. Results are expressed as
percentage of increase over the mean of unstimulated controls.
DOI: 10.1371/journal.ppat.0020019.g007
Figure 8. BDV P Interferes with PKC-Dependent Phosphorylation
(A) Phosphorylation of MARCKS following treatment with PMA was
analyzed in neurons transfected with expression vectors for GFP, BDV
P, and BDV N. b-Tubulin III is used to normalize expression. Results
are expressed as percentage of non-stimulated GFP-transfected
neurons.
(B) Immunofluorescence analysis of BDV P expression in neurons
transfected with increasing quantities of the BDV P plasmid (pCAG-P).
When necessary, the amount of pCAG-P plasmid was supplemented with
empty plasmid (i.e., the same pCAG plasmid backbone without insertion
of P), so that the total amount is 3 lg in all cases Note that BDV P is
detected in neuronal processes, starting at 0.3 lg pCAG-P used in the
transfection.
(C) Dose-dependent interference of BDV P with PKC signaling.
Phosphorylation of MARCKS following treatment with PMA was analyzed
in neurons transfected with increasing quantities of BDV P plasmid
(pCAG-P). The results are representative of four to seven independent
experiments. Results are expressed as percentage of unstimulated
neurons transfected with the empty vector.
(D) BDV P is phosphorylated by PKC following treatment with PMA. BDV
P was immunoprecipitated from BDV-infected neurons and subjected to
Western blot analysis with a phospho-serine antibody. The membrane
was then stripped and subjected to staining for BDV P. The phospho-
serine positive band co-localizes with the band corresponding to P and is
no longer detected in neurons preincubated with PKC inhibitor Bis.
Single asterisk (*) indicates p , 0.05; double asterisks (**) indicate p ,
0.01 by unpaired t test.
DOI: 10.1371/journal.ppat.0020019.g008
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cytoskeletal plasticity [41] and has been associated with PKC-
mediated enhancement of neurotransmitter release, as well as
with persistence of LTP in vivo [42]. Furthermore, PKC-
dependent phosphorylation of the presynaptic protein
Munc18 regulates neurotransmitter release and has been
implicated in presynaptic plasticity [35].
Interestingly, inhibition of the phosphorylation of endog-
enous PKC substrates was also observed after transfection of
neurons with BDV P. P, a cofactor for the viral polymerase
complex, is abundantly expressed in the CNS following
infection and was previously shown to be phosphorylated
by PKC [38], consistent with our ﬁndings that P is
phosphorylated at serine residues following PMA treatment.
How could BDV P interfere with PKC-dependent phosphor-
ylation in neurons? It is conceivable that the activity of PKC
depends on the accessibility and the concentration of its
substrates in the cell, and we postulate that the accumulation
of a viral protein that can serve as a substrate for PKC may
compete with the phosphorylation of endogenous PKC
targets. Very recently, it was shown that BDV P can inhibit
the Traf family member–associated NF-jB (TANK)-binding
kinase-1 (TBK-1) in non–neuronal cells and that it may act as
a decoy substrate, impairing the phosphorylation of endog-
enous TBK-1 substrates [43]. It would be interesting to test
whether the same mechanism also applies to PKC-dependent
signaling in neurons.
Expression of P in glial cells of transgenic mice leads to
behavioral abnormalities [44]. Our results suggest that the
expression of P in neurons, the main target cells for BDV
persistence, is likely to cause neurobiological disturbances,
through interference with PKC signaling. BDV replication is
tightly regulated by complex mechanisms and the phosphor-
ylation of P by PKC could increase the activity of the viral
polymerase complex, thereby contributing to BDV adapta-
tion to persistence in neurons [45,46]. We propose that the
stimulation of synaptic connections of infected neurons, for
example during learning, leads to increased phosphorylation
of P consecutive to PKC activation and hence to increased
viral replication and spread in the CNS, at the expense of
behavioral disabilities for the host. This could also be one of
the reasons for the preferential tropism of BDV for the
hippocampus, a brain area subjected to important synaptic
remodeling and characterized by strong PKC activity [38].
We previously described that BDV blocks ERK 1/2
activation in response to brain-derived neurotrophic factor
(BDNF) [17]. This interference was demonstrated downstream
of its tyrosine kinase receptor TrkB, but the precise link with
impaired ERK activation remained to be identiﬁed. Here, we
showed that the stimulation with glycine did not interfere
with ERK 1/2 activation, suggesting that some pathways
leading to ERK 1/2 activation are preserved following
infection with BDV. It is well known that several intracellular
pathways can mediate ERK phosphorylation in response to
neurotrophins or other extracellular signals [47,48]. In
addition to the linear Ras/cRaf/MEK/ERK pathway, members
of the PKC family have also been shown to mediate ERK
activation. Whether impairment of PKC signaling may in fact
explain the inhibition of neurotrophin response in BDV-
infected neurons is currently under study.
PKC has long been suggested to play important roles in
modulating synaptic efﬁcacy, in particular through the
regulation of vesicular cycling and neurotransmitter release
[49]. Mice knockout for PKC-c exhibit defects in LTP and
learning [50], and impaired PKC activity has been associated
with several neurobehavioral disorders and with neuro-
degenerative diseases such as Alzheimer’s disease [51,52].
Thus, changes in PKC signaling and in presynaptic potentia-
tion observed in BDV-infected neurons could critically affect
learning and behavior. Our ﬁndings provide a molecular basis
for the neurobehavioral and cognitive deﬁcits that are
associated with BDV persistence in the CNS.
Materials and Methods
Primary culture and virus. Hippocampal neurons were prepared
from newborn rats and infected with cell-free BDV (strain He/80), as
described in [22]. BDV infection of neurons was veriﬁed by
immunoﬂuorescence for each experiment [17]. Neuronal cultures
contained more than 80% neurons, as assessed by staining with
neuron-speciﬁc markers, and all neurons were infected at the time
experiments were performed (unpublished data).
Antibodies and reagents. We used: mouse monoclonal antibodies
to the luminal domain of synaptotagmin I (Syt-ecto, clone 604.1,
Synaptic Systems, Goettingen, Germany), Munc18 (Transduction
Laboratories, Lexington, Kentucky, United States), NMDA receptor
type 1 (NR1, clone 54.1; PharMingen, San Diego, California, United
States), phospho-serine (Qiagen SA, Courtaboeuf, France), PKCa
(clone MC5, sc-80; Santa Cruz Biotechnology, Santa Cruz, California,
United States); rabbit polyclonals to the cytoplasmic domain of
synaptotagmin I (Total-Syt; Synaptic Systems), phospho-MARCKS
(Ser152/156, a site speciﬁcally phosphorylated by PKC; Cell Signaling
T e c h n o l o g y ,D a n v e r s ,M a s s a c h u s e t t s ,U n i t e dS t a t e s ) ,M A R C K S
(Chemicon), PKCe (Upstate, Charlottesville, Virginia, United States),
PKCc and PKCd (sc-211 and sc-937, Santa Cruz Biotechnology).
Phospho-Munc18 antibody was a gift from A. Morgan (University of
Liverpool, Liverpool, United Kingdom). Antibodies speciﬁc for
synapsin I phosphorylated by CaMK II at site 3 (clone RU19), or by
PKA and CaMK I at site 1 (clone G257) were provided by P.
Greengard (The Rockefeller University, New York, New York). All
other antibodies have been described in [17]. Pharmacological agents
were used at the following concentrations: 500 nM PMA, 50 lM
forskolin and 1 lM tetrodotoxin (TTX; Sigma-Aldrich, Lyon, France),
200 nM Ro-31–8220 (Bis), a PKC inhibitor, and 20 lM H89, a PKA
inhibitor (Calbiochem, San Diego, California, United States), 50 lM
of NMDA receptor blocker D-(-)-2-amino-5-phosphopentanoic acid
(APV) and 20 lM of AMPA/kainate receptor blocker 6-cyano-7-
nitroquinoxaline-2,3-dione disodium (CNQX; Tocris Bioscience,
Bristol, United Kingdom ). Botulinum B toxin (30 mM) was a gift
from M. Popoff (Institut Pasteur, Paris, France).
Exo-endocytotic assay. The procedure for the analysis of SV
recycling was adapted from a previously described method [20,53].
Experiments were performed at 37 8C in Tyrode’s solution (119 mM
NaCl/5 mM KCl/2 mM CaCl2/2 mM MgCl2/25 mM Hepes/30 mM
glucose). Recycling SV were labeled with Syt-ecto, incubated on living
neurons. Spontaneous SV recycling was measured in Tyrode’s
solution containing TTX, APV, and CNQX. Evoked SV recycling
was measured in high-K
þTyrode’s solution (equimolar substitution of
70 mM KCl for NaCl) containing APV and CNQX, to prevent
recurrent activity due to endogenous glutamate release. Other
measurements were done after stimulation with pulses of high-K
þ
Tyrode’s solution, or with modiﬁed Tyrode’s solutions containing:
glycine (200 lM glycine, 20 lM bicuculline, 1 lM strychnine), PMA, or
forskolin. At the end of stimulation, neurons were allowed to rest for
10 min in the incubator, prior to measurement of post-stimulus
spontaneous SV recycling. Neurons were then processed for
immunocytochemistry, as described in [17]. Binding of Syt-ecto and
total-Syt was revealed with anti mouse-Cy3 and anti rabbit-FITC
secondary antibodies, respectively.
Image acquisition and analysis. Images were acquired using an
epiﬂuorescence microscope (Zeiss Axiovert 200M; Le Pecq, France )
equipped with a Roper Scientiﬁc Coolsnap HQ camera and a 633oil
immersion objective (Roper Scientiﬁc, Trenton, New Jersey, United
States). Acquisition and analysis were carried out using SimplePCI
(Compix, Hamamatsu Photonics Management Corporation, Dela-
ware, United States). Coverslips were coded so that the investigator
was blind to experimental conditions. Puncta with a ﬂuorescence
intensity in the total-Syt channel exceeding a threshold set above
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neuronal contacts. For each synapse, we measured mean ﬂuorescence
intensities for Cy3 (F1) and FITC (F2). After background subtraction,
the ratio of ﬂuorescence intensities F1/F2 was calculated, correspond-
ing to normalized presynaptic activity.
Calculation of presynaptic activities. In order to compare a
population of synapses, we plotted F1/F2 ratios measured at
individual synapses against their frequency of occurrence to obtain
frequency distribution plots (not shown). We then calculated the
integral of the frequency distribution to obtain the cumulative
probability distribution curves, shown in Figures 2, 3, and 5. A shift to
the right indicates an increase in the number of synapses with high
SV recycling. For the analysis of SV recycling from several
independent experiments, we calculated for each experiment the
mean presynaptic activity. To analyze the impact of treatments
(Figures 3 and 5), means were expressed as the percentage of increase
over means under basal conditions. Due to intrinsic variability
between neuronal preparations, analysis was done by comparing
pairwise mean presynaptic activities from control and BDV-infected
cultures prepared and analyzed on the same day.
Plasmids and transfection. BDV P and BDV N were expressed in
pCA vectors [54]. Transfections were performed with the rat Neuron
Nucleofector Kit (Amaxa GmbH, Cologne, Germany), and transfected
neurons were analyzed after 7 d. Transfection rates (veriﬁed by
immunoﬂuorescence) were always around 80%.
PKC assays. Basal and cofactor-stimulated PKC activities were
measured using SignaTECT PKC Assay System (Promega, Charbon-
nie `res, France). Values for reactions lacking the substrate peptide
were subtracted as blanks and speciﬁcity of reaction was veriﬁed by
adding Bis.
Subcellular fractionation. Neurons were fractionated according to
[37]. In brief, cells were lysed in 150-ll buffer A (12.5 mM Tris-HCl/2.5
mM EGTA/1 mM EDTA/100 mM NaF/5 mM DTT/300 lM PMSF/0.05%
digitonin) and centrifuged. The soluble fraction was retained. The
particulate fraction was washed and solubilized in 150 ll of buffer A
containing 1% Triton X-100. Equal volumes of both fractions were
subjected to Western blot.
Cell extracts, Western blots, and immunoprecipitation. Cell
extracts and Western blots were performed as described in [17].
Densitometric analysis was performed using SCION Image (Scion,
Frederick, Maryland, United States). Quantiﬁcation of protein
phosphorylation was carried out by measuring the density of the
band corresponding to the phosphorylated protein normalized by the
expression of the unphosphorylated protein, except for MARCKS
phosphorylation which was normalized by b-tubulin III expression,
due to inefﬁcient stripping of phospho-MARCKS antibody binding.
Results are expressed as percentage of increase over the mean of
unstimulated controls. Immunoprecipitation of BDV P was per-
formed according to [38].
Data analysis. Data are presented as mean 6 standard error of the
mean. The Kolmogorov-Smirnov test (KS) was used to compare the
cumulative probability distributions of F1/F2 ratios. For experiments
analyzing changes in mean presynaptic activities, statistical signiﬁ-
cance was assessed using the paired, two-tailed Student’s t test. For
the other data, statistical signiﬁcance was assessed using the unpaired,
two-tailed Student’s t test.
Supporting Information
Accession Numbers
The SwissProt (http://www.expasy.org/sprot) accession numbers for
proteins mentioned in the text are BDNF (P23363), BDV nucleopro-
tein (Q01552), BDV phosphoprotein (P26668), CaMK (P11275), EBV
Zebra (P03206), ERK 1 and 2 (P21708 and P63086), HIV Nef
(Q9QPN3), MARCKS (P30009), Munc13 (Q62768), Munc18/nSec1
(P61765), PKCa (P05696), PKCe (P09216), PKCc (P63319), PKCd
(P09215), RACK1 (P63245), synapsin 1 (P09951), synaptotagmin 1
(P21707), TBK-1 (Q9WUN2), VAMP-2 (P63045). The GenBank (http://
www.ncbi.nlm.nih.gov/Genbank) for the strain discussed in this paper
is BDV strain He/80/FR (AJ311522).
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